hsa-miR-520d-3p and hsa-miR-449a are Candidate MicroRNA Regulators in Multiple Sclerosis

Area of Science:

• Neuroscience
• Genomics
• Biomarker Discovery

Background:

• Multiple sclerosis (MS) is a chronic inflammatory neurodegenerative disease.
• Characterized by lymphocyte infiltration into the central nervous system.
• Identifying specific microRNAs (miRNAs) could aid MS diagnosis and therapy selection.

Purpose of the Study:

• To identify specific miRNAs with altered expression in multiple sclerosis (MS).
• To explore the potential of these miRNAs as biomarkers for MS diagnosis and therapy.
• To investigate the role of hsa-miR-520d-3p and hsa-miR-449a in MS pathogenesis.

Main Methods:

• Utilized the GSE21079 dataset from the Gene Expression Omnibus database.
• Constructed a miRNA-miRNA interaction network using Bayesian networks and analyzed in Cytoscape.
• Validated candidate miRNA expression (hsa-miR-520d-3p, hsa-miR-449a) via RT-PCR in MS patients and healthy controls.

Main Results:

• Identified hsa-miR-520d-3p and hsa-miR-449a targeting the Notch1 signaling pathway in MS patients.
• Observed downregulation of LASP1, TUBA1C, and S100A6 genes.
• RT-PCR confirmed statistically significant downregulation of hsa-miR-520d-3p (3.1-fold) and hsa-miR-449a (13.3-fold) in MS patients.

Conclusions:

• MS patients exhibit significantly lower expression levels of hsa-miR-520d-3p and hsa-miR-449a.
• These miRNAs represent potential diagnostic and therapeutic biomarkers for multiple sclerosis.
• Further research into their role in MS pathogenesis is warranted.